Joshua Budhu, Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
“Our new study is out in the American Journal of Clinical Oncology, examining how travel distance influences access to radiotherapy for patients with WHO grade 2–3 meningiomas.
Using National Cancer Database data from over 14,000 patients, we found that: Patients living farther from treatment facilities were less likely to receive adjuvant radiotherapy.
Among those receiving radiation, greater travel distance was associated with increased use of shorter stereotactic radiation regimens.
These findings highlight how geographic barriers may influence not only whether patients receive cancer treatment, but also the type of care they receive.
Addressing geographic disparities is essential to improving equitable access to neuro-oncology care.
Grateful to Nipun Gorantla, Edward Christopher Dee and our collaborators for their work on this study.”
Title: Patient-Facility Distance and Adjuvant Radiotherapy for WHO Grade 2-3 Meningioma
Authors: Nipun Gorantla, Connor J. Kinslow, Dylan K. Kim, George Ashji, Sruthi Ranganathan, Joshua A. Budhu, Divya Yerramilli, James Janopaul-Naylor, Andrew R. Barsky, Gustav Cederquist, Brandon S. Imber, Melissa R. Zinovoy, Luke R. G. Pike, Edward Christopher Dee
Other articles about meningiomas and neuro-oncology on OncoDaily.